Lise Brøndsted

Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes

Elisabeth R. Mathiesen, Moshe Hod, Marina Ivanišević et al. · Diabetes Care · 2012 · 217 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

Tim Heise, Ulrike Hövelmann, Lise Brøndsted et al. · Diabetes Obesity and Metabolism · 2015 · 146 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes

Moshe Hod, Elisabeth R. Mathiesen, Lois Jovanovič et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 2013 · 99 citations · Full text

Medicine, Endocrinology, Obstetrics +13

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

Bernhard O. Boehm, Julius A Vaz, Lise Brøndsted et al. · European Journal of Internal Medicine · 2004 · 98 citations

Medicine, Endocrinology, Pharmacotherapy +14

237-OR: Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes

Ulrike Hövelmann, Lise Brøndsted, Niels Rode Kristensen et al. · Diabetes · 2020 · 48 citations

Medicine, Pharmacokinetics, Pharmacology +15